• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核苷酸寡聚化结构域样受体信号增强体内树突状细胞介导的交叉呈递。

Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo.

机构信息

Department of Immunology, Akita University Graduate School of Medicine, Akita, Japan.

出版信息

J Immunol. 2010 Jan 15;184(2):736-45. doi: 10.4049/jimmunol.0900726. Epub 2009 Dec 11.

DOI:10.4049/jimmunol.0900726
PMID:20008287
Abstract

Nucleotide oligomerization binding domain (Nod)-like receptors are critical cytosolic sensors for the recognition of bacterial peptidoglycan. However, their role in the induction of dendritic cell (DC)-mediated cross-priming remains unclear. In this study, we demonstrate that injecting ligands for Nod1 and Nod2 along with Ag into wild-type mice significantly enhanced the cross-priming of Ag-specific CD8+ T cells by CD8alpha+ DCs, as assessed from the expansion of IFN-gamma+ CD8+ T cells, CTL activity against Ag-pulsed targets, and the rejection of transplanted tumors expressing the cognate Ag. The enhancement of CD8alpha+ DC-mediated cross-priming was likely due to the upregulation of Ag cross-presentation and of costimulatory molecules. Our findings collectively indicate that Nod1/2 signaling is critical for the optimal induction of DC cross-priming in vivo, which may offer an alternative therapeutic pathway in cancer and hosts refractory to TLR signals or paralyzed by viral evasion strategy.

摘要

核苷酸寡聚化结构域(Nod)样受体是细菌肽聚糖识别的关键细胞溶质传感器。然而,它们在树突状细胞(DC)介导的交叉呈递中的作用仍不清楚。在这项研究中,我们证明了在野生型小鼠中注射 Nod1 和 Nod2 的配体以及 Ag 可以显著增强 Ag 特异性 CD8+T 细胞由 CD8α+DC 的交叉呈递,这可以从 IFN-γ+CD8+T 细胞的扩增、CTL 对 Ag 脉冲靶标的活性以及对表达同源 Ag 的移植肿瘤的排斥中得到评估。CD8α+DC 介导的交叉呈递的增强可能是由于 Ag 交叉呈递和共刺激分子的上调。我们的研究结果表明,Nod1/2 信号对于体内 DC 交叉呈递的最佳诱导至关重要,这可能为癌症和对 TLR 信号不敏感或被病毒逃避策略麻痹的宿主提供了一种替代的治疗途径。

相似文献

1
Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo.核苷酸寡聚化结构域样受体信号增强体内树突状细胞介导的交叉呈递。
J Immunol. 2010 Jan 15;184(2):736-45. doi: 10.4049/jimmunol.0900726. Epub 2009 Dec 11.
2
Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.甲型流感病毒感染以 TLR7 和 I 型干扰素依赖的方式增强 CD8+ T 细胞对细胞相关抗原的交叉呈递。
J Immunol. 2010 Nov 15;185(10):6013-22. doi: 10.4049/jimmunol.1002129. Epub 2010 Oct 18.
3
Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming.Ⅰ 型干扰素控制摄取肿瘤凋亡细胞后 CD8α(+)树突状细胞的抗原保留和存活,从而导致交叉呈递。
J Immunol. 2011 May 1;186(9):5142-50. doi: 10.4049/jimmunol.1004163. Epub 2011 Mar 25.
4
CpG promotes cross-presentation of dead cell-associated antigens by pre-CD8α+ dendritic cells [corrected].CpG 促进前 CD8α+树突状细胞呈递死亡细胞相关抗原[已更正]。
J Immunol. 2011 Feb 1;186(3):1503-11. doi: 10.4049/jimmunol.1001022. Epub 2010 Dec 27.
5
IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens.干扰素α预处理的树突状细胞在诱导针对外源性病毒抗原的交叉启动CD8(+) T细胞方面效率极高。
Eur J Immunol. 2006 Aug;36(8):2046-60. doi: 10.1002/eji.200535579.
6
Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.过氧化物酶体增殖物激活受体γ激活后,抗原交叉呈递增加但交叉启动受损,这是由B7H1上调介导的。
J Immunol. 2009 Jul 1;183(1):129-36. doi: 10.4049/jimmunol.0804260. Epub 2009 Jun 17.
7
Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.摄取抗原特异性树突状细胞释放的外泌体的非特异性CD4(+) T细胞刺激抗原特异性CD8(+) CTL反应和长期T细胞记忆。
J Leukoc Biol. 2007 Oct;82(4):829-38. doi: 10.1189/jlb.0407249. Epub 2007 Jul 11.
8
Innate signaling regulates cross-priming at the level of DC licensing and not antigen presentation.先天信号调节 DC 许可层面的交叉呈递,而不是抗原呈递。
Eur J Immunol. 2010 Jan;40(1):103-12. doi: 10.1002/eji.200939559.
9
Dendritic cells use endocytic pathway for cross-priming class Ib MHC-restricted CD8alphaalpha+TCRalphabeta+ T cells with regulatory properties.树突状细胞利用内吞途径对具有调节特性的Ib类主要组织相容性复合体(MHC)限制的CD8αα⁺TCRαβ⁺T细胞进行交叉致敏。
J Immunol. 2009 Jun 1;182(11):6959-68. doi: 10.4049/jimmunol.0900316.
10
Toll-like receptor 3 promotes cross-priming to virus-infected cells.Toll样受体3促进对病毒感染细胞的交叉启动。
Nature. 2005 Feb 24;433(7028):887-92. doi: 10.1038/nature03326. Epub 2005 Feb 13.

引用本文的文献

1
Distinctive Immune Signatures Driven by Structural Alterations in Desmuramylpeptide NOD2 Agonists.结构修饰的 NOD2 激动剂诱导的独特免疫特征。
J Med Chem. 2024 Oct 10;67(19):17585-17607. doi: 10.1021/acs.jmedchem.4c01577. Epub 2024 Sep 29.
2
Multifaceted roles and regulation of nucleotide-binding oligomerization domain containing proteins.核苷酸结合寡聚化结构域蛋白的多方面作用和调控。
Front Immunol. 2023 Oct 5;14:1242659. doi: 10.3389/fimmu.2023.1242659. eCollection 2023.
3
Microbiota-dependent regulation of costimulatory and coinhibitory pathways via innate immune sensors and implications for immunotherapy.
微生物群通过先天免疫传感器调节共刺激和共抑制途径及其对免疫治疗的影响。
Exp Mol Med. 2023 Sep;55(9):1913-1921. doi: 10.1038/s12276-023-01075-0. Epub 2023 Sep 11.
4
Topical N-phosphonacetyl-l-aspartate is a dual action candidate for treating non-melanoma skin cancer.局部 N-膦酰乙酰基-L-天冬氨酸是一种治疗非黑素瘤皮肤癌的双重作用候选药物。
Exp Dermatol. 2023 Sep;32(9):1485-1497. doi: 10.1111/exd.14853. Epub 2023 Jun 13.
5
Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency.发现具有个位数纳摩尔效力的去甲muramyl肽NOD2激动剂。
ACS Med Chem Lett. 2022 Jul 18;13(8):1270-1277. doi: 10.1021/acsmedchemlett.2c00121. eCollection 2022 Aug 11.
6
Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagement Promotes Non-Specific Immune Response Against K562 Cancer Cells.核苷酸结合寡聚化结构域1/ Toll样受体4共同参与促进对K562癌细胞的非特异性免疫反应。
Front Pharmacol. 2022 Jul 22;13:920928. doi: 10.3389/fphar.2022.920928. eCollection 2022.
7
peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy.肽聚糖重塑促进检查点抑制剂癌症免疫疗法。
Science. 2021 Aug 27;373(6558):1040-1046. doi: 10.1126/science.abc9113.
8
Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their Adjuvant Activity.结构精细调整脱酰基肽 NOD2 激动剂定义了它们的佐剂活性。
J Med Chem. 2021 Jun 10;64(11):7809-7838. doi: 10.1021/acs.jmedchem.1c00644. Epub 2021 May 27.
9
NOD1 and NOD2 in inflammatory and infectious diseases.NOD1 和 NOD2 在炎症和传染病中的作用。
Immunol Rev. 2020 Sep;297(1):139-161. doi: 10.1111/imr.12902. Epub 2020 Jul 17.
10
Endoplasmic Reticulum-Associated Degradation-Dependent Processing in Cross-Presentation and Its Potential for Dendritic Cell Vaccinations: A Review.内质网相关降解依赖性交叉呈递过程及其在树突状细胞疫苗接种中的潜力:综述
Pharmaceutics. 2020 Feb 13;12(2):153. doi: 10.3390/pharmaceutics12020153.